Sirnaomics

Sirnaomics is a clinical stage biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.

Industries

Headquarters

Gaithersburg, United States

Stage

Series E

Employees

51-200

Links

Org chart

Chairman, President & CEO

Collapse

Chief Financial Officer

Michael Molyneaux

Chief Medical Officer

David Mark Evans

Chief Scientific Officer

Dmitry Samarsky

Chief Technology Officer

Chief Operation Officer

COO, China & Secretary

VP, Chief Scientific Officer - China

VP, Corporate Finance & CFO, China

VP, Regulatory Compliance & CTO, China

John Buergenthal

VP, Human Resources

Richard W. Welch

VP, CMC

Jacqueline A. Dombroski

VP, Regulatory Affairs

Teams

View all

Leadership Team

10 members

CEO and Executive Team

9 members

Discover similar companies

TRICIDA

South San Francisco, United States · Post IPO Debt

Bizzabo

New York, United States · Series E

HoneyBook

San Francisco, United States · Series E

Plastiq

San Francisco, United States · Series E

Allurion

Wellesley, United States · Series D

Axonius

New York, United States · Series E

Providence Medical Technology

Lafayette, United States · Debt Financing

Inkling

San Francisco, United States · Series E

EarlySense

Waltham, United States · Series H

MakeSpace

New York, United States · Series E

PubNub

San Francisco, United States · Series E

Emmaus Medical

Torrance, United States · Post IPO Equity

Two candidates

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.